High-Resolution Respirometry to Assess Bioenergetics in Cells and Tissues Using Chamber- and Plate-Based Respirometers
October 26th, 2021
5.4K views
Assessing oxidative phosphorylation using high-resolution respirometers has become an integral part of the functional analysis of mitochondria and cellular energy metabolism. Here, we present protocols for the analysis of cellular energy metabolism using chamber and microplate-based high-resolution respirometers and discuss the key benefits of each device.
Overview
This study investigates oxidative phosphorylation in mitochondria as a critical aspect of cellular energy metabolism. Using high-resolution respirometers, the research presents protocols for analyzing cellular energy metabolism and highlights the benefits of different respirometry devices.
Key Study Components
Research Area
- Cellular energy metabolism
- Oxidative phosphorylation
- Mitochondrial dysfunction and disease
Background
- Mitochondria are essential for energy production in cells.
- Dysfunction in mitochondria is linked to various diseases.
- High-resolution respirometry enables real-time insight into mitochondrial bioenergetics.
Methods Used
- High-resolution respirometers for measuring oxygen consumption.
- HEK293 cells as the primary biological model.
- Protocols for both chamber and microplate-based assays.
Main Results
- Establishment of protocols for consistent assessment of mitochondrial function.
- Characterization of oxygen consumption in CRISPR-modified HEK293 cells.
- Comparison of respiration rates between different tissue types.
Conclusions
- The study validates the efficacy of high-resolution respirometry in assessing mitochondrial function.
- Results contribute to understanding mitochondrial roles in various diseases.
Frequently Asked Questions
What is oxidative phosphorylation?
Oxidative phosphorylation is the metabolic pathway through which cells generate ATP, using oxygen to help convert nutrients into energy.
Why is mitochondrial function important?
Mitochondrial function is crucial for energy production and overall cellular metabolism, and dysfunctions can lead to various diseases.
How does high-resolution respirometry work?
High-resolution respirometry measures the oxygen consumption of cells to assess mitochondrial energy production in real-time.
What cell line was used in this study?
HEK293 cells were used as the biological model in this research.
What were the main findings related to CRISPR-knockouts?
The study found impaired respiration in CRISPR-knockout cell lines, indicating deficiencies in oxidative phosphorylation.
What is the significance of comparing tissue types?
Comparing tissues, such as mouse cerebellum and soleus muscle, provides insights into the varying capacities for mitochondrial respiration and energy production across different cell types.
How do the methods used contribute to biological research?
These methods enhance our understanding of cellular metabolism, helping to diagnose and explore therapies for mitochondrial diseases.
Executive Industry Relevance
High-resolution respirometry (HRR) enables precise, real-time quantification of mitochondrial bioenergetics in both cultured cells and tissues, supporting mechanistic de-risking and target validation in early discovery. By distinguishing defects in oxidative phosphorylation and respiratory complexes, HRR informs predictive confidence at critical inflection points in disease-relevant model systems and portfolio triage.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Directly interrogates mitochondrial function to clarify disease mechanisms and validate therapeutic targets.
- Enables functional assessment of genetic modifications, such as CRISPR knockouts, for mechanistic de-risking.
- Supports predictive confidence by quantifying respiratory defects and compensatory metabolic shifts.
Screening & Assay Development
- Prepares validated cellular and tissue systems for downstream compound screening workflows.
- Delivers standardized, quantitative oxygen consumption and acidification rate outputs for assay reproducibility.
- Facilitates normalization to cell number or protein content, ensuring reliable cross-sample comparisons.
Translational & Preclinical Research
- Aligns mitochondrial bioenergetics data with disease-relevant tissue models, such as brain and muscle.
- Enables translational continuity by comparing metabolic phenotypes across engineered cell lines and tissues.
- Supports risk-adjusted advancement decisions by revealing compensatory metabolic pathways.
Pipeline & Workflow Integration
HRR integrates from early discovery through preclinical research, bridging hypothesis testing, target validation, and translational model assessment.
- Discovery Biology: Quantifies mitochondrial dysfunction to support hypothesis-driven target selection and pathway clarification.
- Screening: Provides reproducible, quantitative readouts for assay development and compound evaluation.
- Analytics: Enables normalization and statistical comparison of respiratory states and flux control ratios.
- Translational Research: Connects cellular and tissue-level bioenergetics for disease model alignment.
- Enterprise Reuse: Offers a standardized platform adaptable to diverse cell types and tissues for ongoing R&D needs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in mitochondrial disease models.
- Operational Value: Delivers standardized, scalable protocols for both chamber- and plate-based systems.
- Strategic Value: Improves go/no-go decisions and capital efficiency by enabling early detection of metabolic liabilities.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of disease-relevant targets and models.
Implementation Considerations
- Requires expertise in mitochondrial biology and quantitative bioenergetics analysis.
- Demands access to high-resolution chamber- or plate-based respirometry instrumentation.
- Necessitates rigorous cross-team standardization of sample preparation and normalization protocols.
- Adaptation across cell lines and tissues may require optimization of seeding density and assay conditions.
- Sample integrity and rapid processing are critical to preserve mitochondrial function and data quality.
Biopharma FAQs
Why does null hypothesis testing matter for SUIT protocol target validation?
Null hypothesis testing in SUIT protocols enables objective determination of whether observed respiratory changes in engineered or treated cells are statistically significant, supporting robust target validation and reducing false positives in early discovery.
How does independent variable isolation in CRISPR knockout analysis fit the discovery pipeline?
Isolating the genetic variable via CRISPR knockout allows direct attribution of respiratory defects to specific gene disruptions, clarifying mechanistic links and informing target prioritization within the discovery pipeline.
What do quantitative oxygen consumption measurements enable in comparative tissue studies?
Quantitative oxygen consumption measurements allow precise comparison of mitochondrial function across tissues, enabling identification of disease-relevant metabolic phenotypes and supporting translational model selection.
Why are replication requirements critical for cross-functional respirometry workflows?
Replication ensures that observed differences in respiration or metabolic compensation are reproducible and reliable, facilitating cross-functional collaboration and data integration across discovery and translational teams.
What statistical analysis capabilities are required before implementing HRR data in R&D?
Robust statistical analysis, including normalization to protein or cell number and calculation of flux control ratios, is essential to validate findings and support data-driven decisions in biopharma R&D workflows.
Chapters in this video
0:04
Introduction
1:01
High-Resolution Respirometry: Chamber-Based Respirometer (cHRR)
4:51
High-Resolution Respirometry: Microplate-Based Respirometer (mHRR)
6:48
Results: Oxygen Consumption Traces from cHRR and mHRR Using HEK293 Cells with Combined OXPHOS Deficiency
8:53
Conclusion
